Fig. 2
From: Comparative evaluation of α-galactosidase A infusions for treatment of Fabry disease
Frequency of clinical manifestations among Fabry hemizygotes (beige) and heterozygotes (red). TIA, transient ischemic attack; CVA, cardiovascular accident; LVH, left ventricular hypertrophy.
